Thalidomide in patients with cachexia due to terminal cancer: preliminary report.
Bruera
E
E
Division of Palliative Care Medicine, University of Alberta, Cross Cancer Institute, Edmonton, Canada.
Neumann
C M
CM
Pituskin
E
E
Calder
K
K
Ball
G
G
Hanson
J
J
D000368:Aged; D001066:Appetite / Q000187:drug effects; D002100:Cachexia / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000150:complications*; D010865:Pilot Projects; D013727:Terminal Care / Q000379:methods; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use*
D006993:Hypnotics and Sedatives; D013792:Thalidomide